Medical Xpress·3 min read·medium
Artemisinin resistance is rising in East Africa-leaving anti-malarials at risk of failure
R
Ryan O'Hare
✦AI Summary
A study published in The Lancet Infectious Diseases reveals that malaria parasites in East Africa are increasingly developing resistance to artemisinin, the primary drug used in standard treatments. Researchers warn that this trend threatens the effectiveness of global malaria control efforts.
edited by Lisa Lock , reviewed by Andrew Zinin
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in